SRT2104 is primarily investigated for its potential in modulating aging-related pathways and improving metabolic health. It activates SIRT1, a member of the sirtuin family of proteins involved in cellular regulation, stress response, and energy metabolism. Due to this activation, it has been studied in preclinical models for extending lifespan and improving healthspan. It shows promise in treating conditions associated with aging, including type 2 diabetes, where it helps improve insulin sensitivity and glucose homeostasis. Research also explores its role in cardiovascular health, demonstrating benefits in reducing inflammation and improving endothelial function. Additionally, SRT2104 has been evaluated for neuroprotective effects in models of neurodegenerative diseases like Alzheimer’s, where it may help preserve cognitive function. In immune regulation, it exhibits anti-inflammatory properties, making it a candidate for conditions involving chronic inflammation. It has also been tested in clinical trials for its effects on immune responses in smokers and patients with inflammatory conditions. While still under investigation, its ability to target fundamental aging processes positions it as a compound of interest in longevity and age-related disease research.